Condition

Neurological Autoimmune Diseases clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Neurological Autoimmune Diseases clinical trials that are recruiting, at sites in 2 countries (most in China (2), Egypt (1)). By phase: Early Phase 1 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Neurological Autoimmune Diseases clinical trials

StudyPhaseWhereStatusRegistered
CNCT19 CAR‑T treatment for relapsed or refractory antibody-mediated neurological autoimmune diseases Early Phase 1 Beijing Recruiting Dec 10, 2025
Therapeutic plasma exchange for immune-mediated neurological diseases — Cairo Recruiting Sep 29, 2025
GT719 injection for recurrent or refractory antibody-mediated neurological autoimmune disease Phase 1 Wuhan, Hubei Recruiting Jun 13, 2025

All recruiting trials (3)

Quick answers

How many Neurological Autoimmune Diseases clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in China (2 trials), Egypt (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Early Phase 1: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.